Global Legalization: Where We Stand in 2026
From Canada to Germany, Uruguay to Malta — a country-by-country guide to the global cannabis reform movement.
The global cannabis landscape in 2026 bears almost no resemblance to the one that existed a decade ago. In 2016, only two countries — Uruguay and Canada — had legalised cannabis for adult use. Today, that number has grown to include Germany, the Czech Republic, Malta, Luxembourg, and South Africa, while 24 US states plus the District of Columbia have ended prohibition within their borders. A reform wave that once seemed improbable is now unmistakable. [MPP (2026)]
Canada remains the most studied model. Since legalisation in October 2018, the country has built a tightly regulated market that balances public health objectives with commercial viability. Provinces control retail distribution, marketing is strictly limited, and a federal excise tax funds addiction research and public education. The results have been broadly positive: illegal market participation has fallen by an estimated 70 percent, youth use has not increased, and opioid overdose deaths in provinces with legal cannabis access have declined modestly but significantly. [Cannabis Europa]
Germany's approach is more cautious but potentially more consequential. The CanG legislation, passed in 2024, permits adults to possess up to 25 grams and grow up to three plants. Regulated non-commercial cannabis clubs, capped at 500 members each, serve as distribution hubs. The model deliberately avoids the corporate consolidation seen in parts of North America, prioritising social equity over market scale. Early data suggests that German consumption patterns have shifted from street purchases to club-sourced product, though enforcement remains uneven across the sixteen Bundesländer. [Cannabis Europa]
The United States presents the most fractured picture. While 24 states have legalised adult use — and 38 have legal medical programmes — cannabis remains a Schedule I substance under federal law. This contradiction creates extraordinary practical difficulties: state-licensed businesses cannot access banking services, deduct ordinary business expenses from federal tax, or transport products across state lines. The result is a market that is legally vibrant but structurally precarious, with federal reform repeatedly promised and repeatedly delayed. Public opinion, tracked consistently by YouGov, shows 68 percent of Americans now support full legalisation — the highest figure ever recorded. [YouGov Tracker]
Uruguay's pioneering model — state-controlled, pharmacy-based distribution with a registry system — has evolved quietly but effectively. Registered users can purchase up to 40 grams per month from licensed pharmacies, join cannabis clubs, or grow their own. The model deliberately avoids commercial marketing and branding. The result is a market that is functional but unglamorous, with no corporate advertising, no product proliferation, and a steady reduction in drug-related incarceration.
The smaller European jurisdictions offer instructive contrasts. Malta legalised in 2021 with a model focused on non-profit cannabis associations, capping membership at 500 and prohibiting advertising entirely. Luxembourg permits home cultivation and has a tightly restricted club model. The Czech Republic, which already had a thriving medical programme and decriminalised possession, moved to full legalisation in 2025 with a regulated commercial market. South Africa's legalisation, ordered by the Constitutional Court in 2018 and formalised by legislation in 2024, permits adult use and home cultivation but has yet to establish a legal retail market.
Why do some countries lag behind? The reasons are political, cultural, and institutional. The United Nations drug conventions, particularly the 1961 Single Convention, provide a legal basis for resistance. The influence of the international alcohol industry, which benefits from cannabis prohibition, is well-documented. And in many countries, the stigma associated with decades of anti-cannabis propaganda continues to shape public opinion, particularly among older voters. Yet the direction of travel is clear: as more countries legalise and the data from their experiences accumulates, the argument for reform becomes harder to resist.
For a comprehensive guide to the legal arguments and the history behind them, explore our legalisation page.
Sources: [MPP (2026)] | [Cannabis Europa] | [YouGov Tracker]